Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Ligresti

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Journal of Medicinal Chemistry|December 5, 2008
New analgesics synthetically derived from the paracetamol metabolite N-(4-hydroxyphenyl)-(5Z,8Z,11Z,14Z)-icosatetra-5,8,11,14-enamideChristian Sinning, Bernhard Watzer, Ovidiu Coste, et al.
Journal of Medicinal Chemistry|March 31, 2006
Development of the first potential covalent inhibitors of anandamide cellular uptakeAniello Schiano Moriello, Laurence Balas, Alessia Ligresti, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|March 15, 2006
Synthesis, conformational analysis and CB1 binding affinity of hairpin-like anandamide pseudopeptide mimeticsMaria Di Marzo, Agostino Casapullo, Giuseppe Bifulco, et al.
British Journal of Pharmacology|October 10, 2013
Prostamide F(2) α receptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibitionAlessia Ligresti, Jose Martos, Jenny Wang, et al.
European Journal of Medicinal Chemistry|October 26, 2018
Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory diseaseClaudia Mugnaini, Alessandro Rabbito, Antonella Brizzi, et al.
International Journal of Molecular Sciences|April 13, 2023
Multicomponent Reaction-Assisted Drug Discovery: A Time- and Cost-Effective Green Approach Speeding Up Identification and Optimization of Anticancer DrugsGiovanni Graziano, Angela Stefanachi, Marialessandra Contino, et al.
Steroids|May 3, 2011
Desulfohaplosamate, a new phosphate-containing steroid from Dasychalina sp., is a selective cannabinoid CB2 receptor ligandGiuseppina Chianese, Ernesto Fattorusso, Orazio Taglialatela-Scafati, et al.
Journal of Medicinal Chemistry|August 6, 2008
Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivoSerena Pasquini, Lorenzo Botta, Teresa Semeraro, et al.
The Journal of Biological Chemistry|October 22, 2002
The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity. Mechanism and regulationGiuseppe Esposito, Alessia Ligresti, Angelo A Izzo, et al.
European Journal of Medicinal Chemistry|July 15, 2019
Structure-activity relationships of thiazole and benzothiazole derivatives as selective cannabinoid CB2 agonists with in vivo anti-inflammatory propertiesAya E Ghonim, Alessia Ligresti, Alessandro Rabbito, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Journal of Medicinal Chemistry|December 5, 2008
New analgesics synthetically derived from the paracetamol metabolite N-(4-hydroxyphenyl)-(5Z,8Z,11Z,14Z)-icosatetra-5,8,11,14-enamideChristian Sinning, Bernhard Watzer, Ovidiu Coste, et al.
Journal of Medicinal Chemistry|March 31, 2006
Development of the first potential covalent inhibitors of anandamide cellular uptakeAniello Schiano Moriello, Laurence Balas, Alessia Ligresti, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|March 15, 2006
Synthesis, conformational analysis and CB1 binding affinity of hairpin-like anandamide pseudopeptide mimeticsMaria Di Marzo, Agostino Casapullo, Giuseppe Bifulco, et al.
British Journal of Pharmacology|October 10, 2013
Prostamide F(2) α receptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibitionAlessia Ligresti, Jose Martos, Jenny Wang, et al.
European Journal of Medicinal Chemistry|October 26, 2018
Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory diseaseClaudia Mugnaini, Alessandro Rabbito, Antonella Brizzi, et al.
International Journal of Molecular Sciences|April 13, 2023
Multicomponent Reaction-Assisted Drug Discovery: A Time- and Cost-Effective Green Approach Speeding Up Identification and Optimization of Anticancer DrugsGiovanni Graziano, Angela Stefanachi, Marialessandra Contino, et al.
Steroids|May 3, 2011
Desulfohaplosamate, a new phosphate-containing steroid from Dasychalina sp., is a selective cannabinoid CB2 receptor ligandGiuseppina Chianese, Ernesto Fattorusso, Orazio Taglialatela-Scafati, et al.
Journal of Medicinal Chemistry|August 6, 2008
Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivoSerena Pasquini, Lorenzo Botta, Teresa Semeraro, et al.
The Journal of Biological Chemistry|October 22, 2002
The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity. Mechanism and regulationGiuseppe Esposito, Alessia Ligresti, Angelo A Izzo, et al.
European Journal of Medicinal Chemistry|July 15, 2019
Structure-activity relationships of thiazole and benzothiazole derivatives as selective cannabinoid CB2 agonists with in vivo anti-inflammatory propertiesAya E Ghonim, Alessia Ligresti, Alessandro Rabbito, et al.
Pageof 12